Raphael Pharmaceutical, Inc. is a clinical-stage biotechnology company. It is focused on providing a novel cannabinoid-based research platform for the treatment of inflammatory diseases. The firm’s product candidate, HPC1, is a cannabinoid formulation developed for the treatment of rheumatoid arthritis. The company was founded in May 2007 and is headquartered in Tel Aviv, Israel.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Raphael Pharmaceutical Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Raphael Pharmaceutical Inc market cap is $4.32M.
What is the 52-week high for Raphael Pharmaceutical Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Raphael Pharmaceutical Inc 52 week high is $1.65 as of September 05, 2025.
What is the 52-week low for Raphael Pharmaceutical Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Raphael Pharmaceutical Inc 52 week low is $0.15 as of September 05, 2025.
What is Raphael Pharmaceutical Inc stock price today?
Raphael Pharmaceutical Inc stock price today is $0.22.
What was Raphael Pharmaceutical Inc stock price yesterday?
Raphael Pharmaceutical Inc stock price yesterday was $0.75.
What is the PE ratio of Raphael Pharmaceutical Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Raphael Pharmaceutical Inc’s P/E ratio is -2.86.
What is the Price-to-Book ratio of Raphael Pharmaceutical Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Raphael Pharmaceutical Inc P/B ratio is -4.1199.
What is the 50-day moving average of Raphael Pharmaceutical Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Raphael Pharmaceutical Inc 50-day moving average is $0.5168.